drugset
drugset / Trial / NCT01250977

Effect of Donepezil on Smoking

NCT01250977 ↗

Phase 2 Completed 30 enrolled Abramson Cancer Center at Penn Medicine
RandomizedParallel-groupDouble-blindSupportive care

Summary

The objective of this proof-of-concept pilot study is to evaluate Donepezil HCL (Aricept) for side effects and effects on smoking behavior and performance on neurocognitive tasks in a population of dependent smokers.

Timeline

Start
2011-01-11
Primary completion
2011-12-06
Completion
2011-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 5 mg Oral

Indications

No indication recorded.